Your browser doesn't support javascript.
loading
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.
Ríos-Hoyo, Alejandro; Cobain, Erin; Huppert, Laura A; Beitsch, Peter D; Buchholz, Thomas A; Esserman, Laura; van 't Veer, Laura J; Rugo, Hope S; Pusztai, Lajos.
Afiliação
  • Ríos-Hoyo A; Yale Cancer Center, Yale School of Medicine, New Haven, CT.
  • Cobain E; University of Michigan, Ann Arbor, MI.
  • Huppert LA; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.
  • Beitsch PD; Dallas Surgical Group, Dallas, TX.
  • Buchholz TA; Scripps Health, Scripps Clinic Medical Group, San Diego, CA.
  • Esserman L; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.
  • van 't Veer LJ; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.
  • Rugo HS; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.
  • Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, CT.
J Clin Oncol ; 42(22): 2632-2636, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38593393
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Receptor ErbB-2 / Terapia Neoadjuvante Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Receptor ErbB-2 / Terapia Neoadjuvante Idioma: En Ano de publicação: 2024 Tipo de documento: Article